James Goydos
| Dr James James Goydos | |
|---|---|
 | |
| Born | |
| 🏳️ Nationality | American |
| 🏫 Education | Doctor of Medicine (MD); Bachelor of Arts (BA) |
| 🎓 Alma mater | Rutgers Robert Wood Johnson Medical School |
| 💼 Occupation | |
| 🌐 Website | https://jamesgoydos.com |
| jamesgoydosmd | |
| jamesgoydosmd | |
| jamesgoydosmd | |
James Goydos, M.D., F.A.C.S. is an American physician and Board Certified Surgeon specializing in Surgical Oncology.[1]. He is a fellow of the American College of Surgeons and certified by the American Board of Surgery. Goydos received a Doctor of Medicine (M.D.) focused in Medicine from Rutgers, Robert Wood Johnson Medical School in 1988.[2] He has co-authored several patents related to methods and compositions for treating cancer[3] and melanoma
| James Goydos | |
|---|---|
| Born | |
| 🏫 Education | Robert Wood Johnson Medical School (MD), University of California Los Angeles (BA) |
| 💼 Occupation | |
| 🌐 Website | https://jamesgoydos.com |
[4].
Career[edit]
Since completing his training as a Surgical Resident at the University of Connecticut School of Medicine and as a Surgical Oncology fellow at The University of Pittsburgh School of Medicine, Dr. James Goydos has worked in the area of melanoma research. He is an academic researcher with experience as a former Professor of Surgery at Robert Wood Johnson Medical School[5]. He has also previously worked as the Section Chief of Melanoma and Soft Tissue Oncology as one of the original faculty members of the Cancer Institute of New Jersey[6][7].
Dr. James Goydos has been recognised several times as a Top Doctor for Cancer Care in the State of New Jersey for his work with the Cancer Institute of New Jersey[8][9][10][11]. James Goydos is a National Cancer Institute funded investigator[12]. Many of Dr. James Goydos' collaborative laboratory research discoveries have been translated into clinical trials for patients with melanoma[13]. He is a public speaker, and has spoken at conferences including the Mollie Biggane Melanoma Foundation Education Symposium[14] and the Melanoma and the Skin Cancer Patient and Caregiver Symposium[15].
Dr. James Goydos is the author or co-author of more than 80 peer-reviewed publications, review articles, book chapters, and published abstracts[16]. He currently serves on the editorial board of the journal Clinical Cancer Research[17].
Dr. James Goydos regularly publishes on Medika Life, Medium, The Good Men Project, Newsbreak, Thrive Global, Hubpages, and other platforms on topics pertaining to melanoma, technology in the medical industry, and other topics related to healthcare.
References[edit]
- ↑ "American College of Surgeons Certification". American College of Surgeons. American College of Surgeons. Retrieved 5 August 2020.
- ↑ O'Neill, Kate; Rudolph, Lynda; Scanlon, Joni (Spring 2009). "Personalized MEDICINE Probing the Human Genome to Advance Patient Care" (PDF). Robert Wood Johnson MEDICINE. 11, Number 1. Retrieved 5 August 2020.
- ↑ Goydos, James; Chen, Suzie. "Methods And Compositions For Treating Cancer". Google Patents. University of Medicine and Dentistry of New Jersey Rutgers State University of New Jersey. Retrieved 5 August 2020.
- ↑ Goydos, James; Chen, Suzie. "Methods and Compositions For Treating Melanoma". Google Patents. Rutgers State University of New Jersey. Retrieved 5 August 2020.
- ↑ [1] Surgical Oncology Program, Rutgers Cancer Institute of New Jersey, Retrieved January 19, 2022.
- ↑ Fisher, Michele (Autumn 2015). "Harnessing Viruses Against Cancer" (PDF). Rutgers Cancer Connection: 16. Retrieved 6 August 2020.
- ↑ [2] Physicians at Rutgers Cancer Institute of New Jersey Named Among ‘Top Docs’ in State; Dr. James Goydos listed, Retrieved January 19, 2022
- ↑ [3] Rutgers Cancer Institute of New Jersey Oncologists Recognized as Tops; Dr. James Goydos Director, Melanoma and Soft Tissue Oncology Program; specialty: melanoma, skin cancer and sarcomas, retrieved January 19, 2022
- ↑ [4] Physicians at Rutgers Cancer Institute of New Jersey Named Among ‘Top Docs’ in State; Dr. James Goydos Director, Melanoma and Soft Tissue Oncology Program; specialty: melanoma, skin cancer and sarcomas; Retrieved January 19, 2022
- ↑ [5] Rutgers Cancer Institute of New Jersey Physicians Named Among 'Tops' in State; Director, Melanoma and Soft Tissue Oncology Program; specialty: melanoma, skin cancer and sarcomas; Retrieved January 19, 2022
- ↑ [6] Physicians at Rutgers Cancer Institute of New Jersey Named Among 'Top Docs' in State; Director, Melanoma and Soft Tissue Oncology Program; specialty: melanoma, skin cancer and sarcomas; Retrieved January 19, 2022
- ↑ "NIH Awards By Location and Organization". National Institute of Health. National Institute of Health. Retrieved 6 August 2020.
- ↑ Blumberg, Joseph. "Early Clinical Trial Results Back New Drug for Melanoma". Rutgers Today. Rutgers University. Retrieved 6 August 2020.
- ↑ "Find Support Mollie Biggane Fund's Annual Educational Symposium". Melanoma Research Foundation. Melanoma Research Foundation. Retrieved 6 August 2020.
- ↑ [7]Goydos, James. Patch.com. Patch.com [Melanoma & Skin Cancer Patient & Caregiver Symposium Melanoma & Skin Cancer Patient & Caregiver Symposium] Check
|url=value (help). Retrieved 7 October 2021. Missing or empty|title=(help) - ↑ "Researchers - James Goydos". Publons. Publons. Retrieved 6 August 2020.
- ↑ "Clinical Cancer Research - Editors". American Association for Cancer Research. American Association for Cancer Research. Retrieved 6 August 2020.
This article "James Goydos" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:James Goydos. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
